Otsuka Holdings Company Ltd. Registered Shares o.N.
- BID
60
- ASK
61
- 105 Units103 Units
- 07/21, 21:59:45 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
57.89%
Market Cap
31.64 Bil.
P/E Ratio
12.95
Dividend Yield
1.58 %
Earnings per Share
4.06 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 60 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:57:14 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 60 | 58.5 |
| PREV. DAY'S PRICE | 60 | (07/20) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 63 (05/21) | 37.6 (07/22) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 1.48 | 3.87 | 4.06 | 3.18 | 3.42 |
DIVIDENDS PER SHARE | 0.73 | 0.73 | 0.83 | 0.76 | 0.86 |
DIVIDEND YIELD IN % | 2.08 % | 1.40 % | 1.58 % | - | - |
DIVIDEND GROWTH IN % | -0.37 % | 1.03 % | 13.20 % | - | - |
PRICE - EARNINGS RATIO | 23.60 | 13.57 | 12.95 | 18.64 | 17.34 |
PRICE - BOOK RATIO | 1.20 | 1.69 | 1.54 | - | - |
PRICE - SALES RATIO | 1.42 | 2.00 | 1.91 | - | - |
PRICE - CASH FLOW RATIO | 10.13 | 13.13 | 11.65 | - | - |
Master Data
| WKN | A1C9KC |
| ISIN | JP3188220002 |
| SYMBOL | OS1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | OtsukaCompany |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Japanese Yen |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 527.31 Mil. |
| MARKET CAPITALISATION | 31.64 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 4.35 % | 6.19 % | 5.26 % | 27.12 % | 57.89 % | 81.82 % | 77.51 % | 25.00 % |
| HIGH | 60.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 |
| LOW | 57.50 | 56.50 | 54.00 | 47.60 | 37.60 | 30.80 | 26.80 | 47.00 |
Dividende
pro Aktie
Company profile
Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.